Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityDividends payablesLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetMortgage LoansNon-Current DebtPayablesPrepaid AssetsReceivables - AccuredRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Ratios

Advanced Flower Capital (AFCG) Liabilities and Shareholders Equity: 2022-2025

Historic Liabilities and Shareholders Equity for Advanced Flower Capital (AFCG) over the last 4 years, with Sep 2025 value amounting to $288.7 million.

  • Advanced Flower Capital's Liabilities and Shareholders Equity fell 21.25% to $288.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 26.28%. This contributed to the annual value of $402.1 million for FY2024, which is 13.83% down from last year.
  • According to the latest figures from Q3 2025, Advanced Flower Capital's Liabilities and Shareholders Equity is $288.7 million, which was down 0.64% from $290.6 million recorded in Q2 2025.
  • Advanced Flower Capital's Liabilities and Shareholders Equity's 5-year high stood at $519.2 million during Q4 2022, with a 5-year trough of $288.7 million in Q3 2025.
  • Over the past 3 years, Advanced Flower Capital's median Liabilities and Shareholders Equity value was $445.1 million (recorded in 2023), while the average stood at $401.6 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first increased by 6.38% in 2024, then tumbled by 36.55% in 2025.
  • Quarterly analysis of 4 years shows Advanced Flower Capital's Liabilities and Shareholders Equity stood at $519.2 million in 2022, then decreased by 10.13% to $466.6 million in 2023, then decreased by 13.83% to $402.1 million in 2024, then decreased by 21.25% to $288.7 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $288.7 million for Q3 2025, versus $290.6 million for Q2 2025 and $321.7 million for Q1 2025.